MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide.
Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide.
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally.
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide.
PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products.
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibodies, and specializes in antibody drug conjugates in Germany.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for out-patient and hospital-based sedation, anesthesia, and critical care services worldwide.
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin.
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs.
Medigene AG, a clinical stage immuno-oncology company, focuses on the development of T cell immunotherapies for the treatment of cancer.
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel treatments for patients suffering from diseases that have unmet medical needs.
4basebio AG, an enabler of advances in medical science and patient care, focuses on manufacturing DNA products for therapeutic and other uses in Europe, the United States, and internationally.
Deutsche Biotech Innovativ AG operates as a biotechnology company in Germany.
CytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies.
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide.
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids.
Epigenomics AG, a cancer molecular diagnostics company, develops and commercializes blood-based diagnostic tests across multiple cancer indications with high medical needs in Europe, North America, Asia, and internationally.
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment.